On January 3, 2022, the Board of Curis, Inc. appointed John A. Hohneker to serve on the Compensation Committee and the Clinical Program Committee, effective immediately, in each case until his successor is duly appointed and qualified or until his earlier resignation or removal.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.64 USD | +1.19% | -33.97% | -18.74% |
May. 14 | Transcript : Curis, Inc. - Special Call | |
May. 14 | Curis, Inc. Announces Additional Data from Take Aim Leukemia Study | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.74% | 62.01M | |
+40.60% | 54.04B | |
+43.57% | 41.96B | |
-1.19% | 41.92B | |
-7.59% | 28.35B | |
+12.38% | 26.35B | |
-22.17% | 19B | |
+7.76% | 13B | |
+28.26% | 12.28B | |
+24.84% | 12.19B |
- Stock Market
- Equities
- CRIS Stock
- News Curis, Inc.
- Curis, Inc. Appoints John A. Hohneker to Compensation Committee and the Clinical Program Committee